Worthing, United Kingdom

Julian S Harber

This inventor holds 1 USPTO granted patent. Top assignee: Beecham Group Plc. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julian S Harber. Retrieved from https://idiyas.com/inventor/julian-s-harber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Julian S Harber

Introduction

Julian S Harber is a notable inventor based in Worthing, GB. He has made significant contributions to the field of biochemistry, particularly in the purification of streptokinase. His work has implications for medical treatments and the pharmaceutical industry.

Latest Patents

Julian S Harber holds a patent for a process titled "Process for purification of streptakinase using a reducing agent." This innovative method involves the separation of streptokinase from contaminating proteins in a streptokinase-containing mixture. The process includes treating the mixture with a reducing agent to reduce disulphide bridges in the contaminating proteins, allowing for the effective isolation of streptokinase in a form that is substantially free of contaminants.

Career Highlights

Harber is associated with Beecham Group Plc, where he has contributed to various projects and research initiatives. His expertise in biochemistry and patentable processes has positioned him as a valuable asset in his field.

Collaborations

Some of his notable coworkers include Christopher J Mannix and Richard A Smith. Their collaborative efforts have likely enhanced the research and development processes within their organization.

Conclusion

Julian S Harber's innovative work in the purification of streptokinase showcases his significant contributions to biochemistry and the pharmaceutical industry. His patent reflects a commitment to advancing medical science and improving treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…